Lisinopril quantification in human plasma by liquid chromatography- electrospray tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 809, Issue 2, 2004, Pages 211-216

  Padua, Ana A F ^a   Barrientos Astigarraga, Rafael E ^b   Rezende, Vinicius M ^b   Mendes, Gustavo D ^b   De Nucci, Gilberto ^a,b,c  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Jesuino Marcondes Machado   (Brazil)

Author keywords

Lisinopril

Indexed keywords

IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; POSITIVE IONS; SPECTROMETERS;

ELECTROSPRAY IONIZATION (ESI); HUMAN PLASMA; MULTIPLE REACTION MONITORING (MRM); TANDEM MASS SPECTROMETRY;

PLASMAS;

ACETIC ACID; ACETONITRILE; ENALAPRILAT; LISINOPRIL; TRIETHYLAMINE; WATER;

ACCURACY; ANALYTIC METHOD; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CALCULATION; CONTROLLED STUDY; DRUG DETERMINATION; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETER; MONITORING; NORMAL HUMAN; POSITIVE ION ELECTROSPRAY; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TABLET FORMULATION; TANDEM MASS SPECTROMETRY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALIBRATION; HUMANS; LISINOPRIL; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; THERAPEUTIC EQUIVALENCY;

EID: 4143150647     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2004.06.021     Document Type: Article

References (18)

1. E.K. Jackson, Renin and Angiotensin, in: Goodman, Gilman (Eds.), The Pharmacological Basis of Therapeutics, 10 ed., The McGraw-Hill Companies, 2002, pp. 809-841.
2. PDR (2003) 692.
3. Sáenz-Campos D., Bayés M.C., Masana E., Martín S., Barbanoj M., Jané F. Meth. Find Exp. Clin. Pharmacol. 18(8):1996;533
4. Worland P.J., Jarrot B. J. Pharm. Sci. 75:1986;512
5. Lancaster S.G., Todd P.A. Drugs. 35:1988;646
6. Bellissant E., Chau N.P., Giudicelli J.F. J. Cardiovasc. Pharmacol. 28:1996;470
7. Johnston D., Duffin D. Am. J. Cardiol. 70:1992;151C
8. Vandenburg M.J., Morris F., Marks C., Kelly J.G., Dews I.M., Stephens J.D. Xenobiotica. 18(10):1988;1179
9. Yuan A.S., Gilbert J.D. J. Pharm. Biomed. Anal. 14:1996;773
10. Leis H.J., Fauler G., Raspoting G., Windischholer W. Rapid Commun. Mass Spectrom. 12:1998;1591
11. Leis H.J., Raspoting G., Windischholer W. Rapid Commun. Mass Spectrom. 13:1999;650
12. Tsakalof A., Bairachtari K., Georgarakis M. J. Chromatogr. B. 783:2003;425
13. Food and Drug Administration, Fed. Reg. 63 (1998) 64222.
14. Ribeiro W., Muscará M.N., Martins A.R., Moreno H., Mendes G.B., Nucci G. Eur. J. Clin. Pharmacol. 50:1996;399
15. El-Gindy A., Ashour A., Abdel-Fattah L.A., Shabana M.M. J. Pharm. Biomed. Anal. 25:2001;913
16. Bonazzi D., Gotti R., Andrisano V., Cavrini V. J. Pharm. Biomed. Anal. 16:1997;431
17. Wong Y.C., Charles B.G. J. Chromatogr. B. 673:1995;306
18. S.C. Sweetman (Ed.), Martindale - The Complete Drug Reference, 33rd ed., Pharmaceutical Press, 2002, p. 921.